New York, US, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.4% in the forecast period from 2020 to 2029.
The global chemotherapy market is expected to reach USD 79.3 billion by 2029.
Cancer is a critical ailment, and the demand for chemotherapy drugs is estimated to rise due to the growing prevalence of cancer. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide. Further, it stated that nearly 9.6 million deaths, i.e., 1 in 6 deaths, were reported due to cancer in 2018. Moreover, growing investment in the research and development of chemotherapy drugs and a surge in awareness towards early cancer diagnosis are driving the global market.
COVID-19: Delayed Chemotherapy and Post-Pandemic Transitions
The chemotherapy market witnessed a loss of business till late December 2020 due to the preventive measures taken during the COVID-19 pandemic. Despite the constant demand for medicines, many pharmaceutical companies experienced challenges in resuming their manufacturing capacity, and industry participants are enduring the effects of shortages in distribution and supply networks.
Many regulatory authorities globally have identified that cancer patients are at higher risk of COVID-19 infection than others. As a result, diagnostic examinations and surgical procedures are limited or postponed, which is liable to cause market disruptions in the chemotherapy market. However, the pandemic has transformed the oncology industry by replacing traditional outpatient practices with digital solutions and employing network teaching. It has also encouraged market players to devise new technologies to sustain themselves in the competitive market.
Get Free Sample Copy of This Report @ https://straitsresearch.com/report/chemotherapy-market/request-sample
Chemotherapy Market by Drug Class
Anti-tumor Antibiotics Spurs Chemotherapy
With an increase in the prevalence of cancer, the demand for chemotherapy drugs is susceptible to exceed. Anti-tumor antibiotics work by stopping or slowing the growth of cancer cells, its high usage for the treatment of cancer is anticipated to hold its dominance over the forecast period. There are several anti-tumor antibiotics, including Anthracyclines, Chromomycin, and Miscellaneous.
Anthracycline in the chemo regime has shown better outcomes than others. For instance, research conducted on 4,130 women with breast cancer treated with Anthracyclines therapy suggests that these women lived longer without the reassurance of cancer. Several examples of Anthracyclines include Doxorubicin, Daunorubicin, Epirubicin, Mitoxantrone, and Idarubicin, among others.
Chemotherapy Market by Indication
The ubiquity of Lung Cancer Dictates the Market
The lung cancer segment accounts for the largest revenue share and is expected to remain dominant over the forecast period. It is because of the growing prevalence of lung cancer and rising research activity in this field. In the United States, lung cancer is the second most common cancer among men and women. According to the American Cancer Society, about 235,760 new cases of lung cancer are estimated in 2021.
Further, as per the Lung Cancer in Asia research paper, May 2020, the most commonly diagnosed cancer in China is lung cancer, with 774,323 new cases diagnosed in 2018. The growing prevalence of lung cancer and unmet patient needs is driving the demand for chemotherapy drugs.
Chemotherapy Market by End-Users
Advanced Medical Technologies Foster Lucrative Opportunities for Hospitals
In terms of the end-user, hospitals accounted for the largest share of the global market in 2020. It is attributed to the rising expenditure by hospitals on chemotherapy drugs and the demand for advanced treatments provided by hospitals.
Chemotherapy Market by Regions
North American Dominion over the Global Chemotherapy Market
North America held a commanding position in revenue and is anticipated to remain dominant over the forecast period. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The growing adoption of advanced cancer therapeutic options coupled with rising cancer incidence is one of the primary growth stimulants for the North American market.
Asia-Pacific Strives to Grow
On the other hand, the Asia-Pacific chemotherapy drugs market will experience promising growth over the forecast period. New and advanced anti-cancer drugs are being introduced in China and Japan. These countries have several ongoing clinical trials and FDA approvals for new drug molecules and combination therapies. The approval of new treatment drugs in China and Japan and a lack of regulatory inhibitions augment the adoption of chemotherapy in the Asia-Pacific market.
Regional Analysis as per the Trends @ https://straitsresearch.com/regional-analysis/chemotherapy-market/global/
Detailed Table of Content
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Chemotherapy Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 By Drug type Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Alkylating Agents
4.2.1 Mustard Gas Derivatives
4.2.2. Ethylenimines
4.2.3 Alkyl Sulfonates
4.2.4 Hydrazines
4.2.5 Triazines
4.2.6 Others
4.3 Antimetabolites
4.4 Anti-Tumor Antibiotics
4.4.1 Anthracyclines
4.4.2 Chromomycin
4.5 Topoisomerase Inhibitors
4.5.1 Topoisomerase I Inhibitors
4.5.2 Topoisomerase Ii Inhibitors
4.6 Mitotic Inhibitors
4.7 Others
5 By Indication Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Leukemia
5.3 Lymphoma
5.4 Breast Cancer
5.5 Ovarian Cancer
5.6 Lung Cancer
5.7 Myeloma
5.8 Sarcoma
5.9 Others
6 By Route of Drug Administration Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 Oral
6.3 Intravenous
7. By End User Type
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 Hospitals
7.3 Research Institutes
7.4 Others
8 Regional Overview
8.1 Introduction
8.1.1 Market Size & Forecast (Value)
8.2 America
8.2.1 North America
8.2.2 Latin America
8.3 Europe
8.3.1 Market Size & Forecast (Value)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.2 Japan
8.4.3 China
8.4.4 Australia
8.4.5 India
8.4.6 South Korea
8.4.7 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Market Size & Forecast (Value)
8.5.2 Saudi Arabia
8.5.3 South Africa
8.5.4 Kuwait
8.5.5 Rest of Middle East & Africa
9 Company Profile
9.1 Delacroix-Chevalier
9.2 FSSB surgical needles GmbH
9.3 Becton, Dickinson, and Company
9.4 B. Braun Melsungen AG
9.5 Sheffield Ltd.
Continue…
Buy Now Full Report @ https://straitsresearch.com/buy-now/chemotherapy-market/
News Media
Everything That You Need to Know About the Life Sciences Industry in 2020
Coronavirus Crisis - Impact Of COVID-19 On Healthcare Industry
Top 7 Players in the Global Ventilators Market
Adoption of Bioplastics and Biopolymers Thrive Towards Sustainability Goals
Have a Look at Related Research Report
Veterinary Oncology Market: Information by Therapy (Surgery, Radiology, Chemotherapy), Animal Type (Canine, Feline), Cancer Type (Lymphoma, Mammary), and Region—Forecast till 2029
Ear Cancer Treatment Market: Information by Therapy (Chemotherapy, Immunotherapy, Surgical Therapy), End-Users (Hospitals and Clinics, Retail Pharmacies), and Region—Forecast Till 2027
Virology Market: Information by Product Type (Diagnosing Test, Antiviral Chemotherapy), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections), and Region—Forecast Till 2026
Stomach Cancer Market: Information by Therapy (Chemotherapy, Surgery), End-User (Hospitals & Clinics, Cancer Research, and Treatment Centers, and Diagnostic Centers)—Forecast Till 2026
Cervical Cancer Treatment Market: Information by Type, and Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy) and Regional Outlook - Forecast Till 2026
Cancer Treatment Market: Information by Therapy (Chemotherapy, Immunotherapy, Hormonal Therapy), Application, End Users and Regional Outlook — Forecast Till 2026
Bioreactors Market: Information by Product Type, Cell (Mammalian Cells), Molecule (Monoclonal Antibodies), Reactor Volume, End-User (R&D Organization), and Region — Forecast till 2029
Women’s Health Care Market: Information by Drug (Vagifem, Lupron, and Yasmin), Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis), and Region—Forecast till 2029
About Straits Research Pvt Ltd
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. StraitsResearch provides the actionable market research data specially designed and presented for the decision making and ROI. Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches.
So let's put our minds together. We'll make your vision a reality and help you grow.
